Pharma & medtech marketing needs an approval process as well as creative work. An unchecked claim or a review reply that exposes private information can undermine trust. This is a working list of questions to check before publication.
The rules and guidelines to check against
- Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
- Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024
- Drugs and Cosmetics Rules on promoting prescription medicines to the public
- ASCI guidelines on health claims
These are pointers for review, not legal advice. Confirm the specifics with a qualified adviser.
What a trustworthy pharma & medtech brand visibly shows
- Approved, referenced product information
- Clear manufacturing and quality credentials
- Pharmacovigilance / adverse-event contact
- Separate HCP information
Common questions to review
Can pharma companies advertise medicines on their website?
Prescription medicines should not be promoted to the public, and certain disease claims are prohibited outright. Corporate information, capabilities and approved product information for professionals are possible with medical and regulatory review.
What is UCPMP 2024?
The Uniform Code for Pharmaceutical Marketing Practices sets expectations for how pharmaceutical companies promote products and engage healthcare professionals, including evidence-based claims and restrictions on gifts and hospitality.
A quick pre-publication check
- Every product claim links to an approved source and a named reviewer.
- Healthcare professionals and the public reach different, appropriate information.
- Corporate, product and therapy-area brands follow one clear hierarchy.
If any of these is a “no”, fix it before spending on promotion. You can score all eight checks in two minutes with the free brand health check.
Want this checked for your pharma manufacturer?
Every published claim connected to an approved source and version. Start with diagnose the problem from ₹40,000, or take the free two-minute brand check.
